Results 231 to 240 of about 2,570,818 (334)

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia   +20 more
wiley   +1 more source

Steroids:Modulators of inflammation and immunity [PDF]

open access: yes, 2010
Chapman, Karen E, Odermatt, Alex
core   +1 more source

Studies on Immunity in Anthrax [PDF]

open access: bronze, 1955
Sidney B. Auerbach, George G. Wright
openalex   +1 more source

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Pure autonomic failure (PAF) presents with autonomic failure without other neurological features. A third develop central neurological features, fulfilling criteria for multiple system atrophy (MSA) and Lewy body diseases (LBD), including Parkinson's disease and Dementia with Lewy bodies.
S. Koay   +12 more
wiley   +1 more source

Advocates' immunity in Scotland [PDF]

open access: yes, 2003
Seneviratne, M
core  

A Physical-Chemical Study of Normal and Immune Horse Sera [PDF]

open access: bronze, 1940
Norbert Fell   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy